Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

In vivo antitumor and apoptosis-inducing activity described for new proteasome inhibitor

May 4, 2001

Dibenzophenanthroline G-quadruplex ligands inhibit telomerase activity

May 4, 2001

MitoExtra and mitomycin C bioequivalent in phase I study

May 4, 2001

Paclitaxel-chlorambucil hybrid shows supraadditive activity in certain tumor models

May 4, 2001

Preparation and use of new VEGF receptor tyrosine kinase modulators reported in recent patent

May 3, 2001

Inhibitors of protein prenyltransferases remain an R&D focus at Merck

May 3, 2001

FDA approves Xeloda for metastatic colorectal cancer

May 3, 2001

Axcan's Photofrin approved and launched in the U.K.

May 3, 2001

Novartis Oncology announces Glivec name change in U.S.

May 3, 2001

Nonestrogenic steroid sulfatase inhibitors identified at Jenapharm

May 2, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...